Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has made significant investments in wealth management products, subscribing to structured deposits across Industrial Bank, CITIC Bank, and CZB, with a total outstanding principal of RMB 1.01 billion. These investments, aimed at enhancing financial returns, have been classified as discloseable transactions under Hong Kong’s Listing Rules due to their substantial size. Investors may find these strategic financial moves noteworthy as they reflect the company’s approach to asset management and risk diversification.
For further insights into HK:6990 stock, check out TipRanks’ Stock Analysis page.